[1] Chopra V, Flanders SA, Saint S, Woller SC, Ogrady NP, Safdar N, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method. Annals of Internal Medicine. 2015;163(6_Supplement).
[2] Corrigan A. Infusion nursing as a specialty. In: Alexander M, Corrigan A, Gorski L, Hankins J, Perucca R, editors. Infusion nursing: An evidence-based approach. 3rd ed. St Louis, US: Saunders/Elsevier; 2010. p. 1-9.
[3] Abolfotouh MA, Salam M, Mustafa AAB, White D, Balkhy H. Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications. Therapeutics and Clinical Risk Management. 2014;:993.
[4] Abdul-Hak CK, Barros ÂF. The incidence of phlebitis in a Medical Clinical Unit. Texto & Contexto - Enfermagem. 2014;23(3):633–8.
[5] Braga LM, Parreira PM, Oliveira ADSS, Mónico LDSM, Arreguy-Sena C, Henriques MA. Phlebitis and infiltration: vascular trauma associated with the peripheral venous catheter. Revista Latino-Americana de Enfermagem. 2018;26.
[6] Danski MTR, Johann DA, Vayego SA, Oliveira GRLD, Lind J. Complicações relacionadas ao uso do cateter venoso periférico: ensaio clínico randomizado. Acta Paulista de Enfermagem. 2016;29(1):84–92.
[7] Ho KH, Cheung DS. Guidelines on timing in replacing peripheral intravenous catheters. Journal of Clinical Nursing. 2012;21(11-12):1499–506.
[8] Morris W. Complications. In: Phillips S, Collins M, Dougherty L., editors. Venepuncture and cannulation. West Sussex: Blackwell Publishing; 2011. p. 175-222.
[9] Park SM, Jeong IS, Kim KL, Park KJ, Jung MJ, Jun SS. The Effect of Intravenous Infiltration Management Program for Hospitalized Children. Journal of Pediatric Nursing. 2016;31(2):172–8.
[10] Perucca R. Peripheral venous access devices. In: Alexander M, Corrigan AG, Hankins JP, editors. Infusion nursing: evidence based approach. 3ª ed. Missouri: Saunders Elsevier; 2010. p. 456-479
[11] Rojas-Sánchez L, Parra D, Camargo-Figuera F. Incidence and factors associated with development of phlebitis: results of a pilot study cohort. Revista de Enfermagem Referência. 2015;IV Série(Nº 4):61–7.
[12] Rickard CM, Mccann D, Munnings J, Mcgrail MR. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Medicine. 2010;8(1).
[13] Salgueiro-Oliveira A, Costa P, Graveto J, Costa F, Osório N, Cosme A, et al. Práticas dos enfermeiros na cateterização intravenosa: um estudo descritivo. Revista de Enfermagem Referência. 2019;IV Série(Nº 21):111–20; doi: 10.12707/riv19006.
[14] Martínez J, Piazuelo M, Almela M, Blecua P, Gallardo R, Rodríguez S, et al. Evaluation of add-on devices for the prevention of phlebitis and other complications associated with the use of peripheral catheters in hospitalised adults: a randomised controlled study. Journal of Hospital Infection. 2009;73(2):135–42.
[15] Wallis MC, Mcgrail M, Webster J, Marsh N, Gowardman J, Playford EG, et al. Risk Factors for Peripheral Intravenous Catheter Failure: A Multivariate Analysis of Data from a Randomized Controlled Trial. Infection Control & Hospital Epidemiology. 2014;35(1):63–8.
[16] Capdevila JA, Guembe M, Barberán J, Alarcón AD, Bouza E, Fariñas MC, et al. 2016 Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adults. Cirugía Cardiovascular. 2016;23(4):192–8.
[17] The 2016 Infusion Therapy Standards of Practice. Home Healthcare Now. 2017;35(1).
[18] Loveday H, Wilson J, Pratt R, Golsorkhi M, Tingle A, Bak A, et al. epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England. Journal of Hospital Infection. 2014;86.
[19] Ogrady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the Prevention of Intravascular Catheter-related Infections. Clinical Infectious Diseases. 2011;52(9).
[20] Marsh N, Webster J, Mihala G, Rickard CM. Devices and dressings to secure peripheral venous catheters to prevent complications. Cochrane Database of Systematic Reviews. 2015.
[21] Goossens GA. Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit. Nursing Research and Practice. 2015;2015:1–12.
[22] Direção Geral de Saúde. Prevalência de infeção adquirida no hospital e do uso de antimicrobianos nos hospitais portugueses: Inquérito 2012. Lisboa: Direção Geral de Saúde; 2013.
[23] Damani N. Manual of Infection Prevention and Control. 3ª ed. United States: Oxford University Press; 2012.
[24] Pina E, Ferreira E, Marques A, Matos B. Infeções associadas aos cuidados de saúde e segurança do doente. Revista Portuguesa de Saúde Pública. 2010; 10:27-39.
[25] Direção Geral de Saúde. Prevenção e controlo de infeções e de resistência aos antimicrobianos em números 2015: Programa de prevenção e controlo de infeções e de resistência aos antimicrobianos. Lisboa: Direção Geral de Saúde; 2016.
[26] Direção Geral de Saúde. Infeções e resistências aos antimicrobianos: relatório anual do programa prioritário. Lisboa: Direção Geral de Saúde; 2018.
[27] Oliveira A, Parreira P. Intervenções de enfermagem e flebites decorrentes de cateteres venosos periféricos: Revisão sistemática da literatura. Referência - Revista Científica da Unidade de Investigação em Ciências da Saúde: Domínio de Enfermagem. 2010; 3(2):137-147.
[28] Braga LM, Pedro Miguel Dos Santos Dinis Parreira, Arreguy-Sena C, Carlos DM, Mónico LDSM, Henriques MAP. Taxa De Incidência E O Uso Do Flushing Na Prevenção Das Obstruções De Cateter Venoso Periférico. Texto & Contexto - Enfermagem. 2018;27(4); doi:10.1590/0104-07072018002810017
[29] Keogh S, Flynn J, Marsh N, Higgins N, Davies K, Rickard CM. Nursing and midwifery practice for maintenance of vascular access device patency. A cross-sectional survey. International Journal of Nursing Studies. 2015;52(11):1678–85.
[30] Royal College of Nursing Standards for infusion therapy. 4th ed. London: Royal College of Nursing; 2016.
[31] Ferroni A, Gaudin F, Guiffant G, Flaud P, Descamps P, Berche P, et al. Pulsative flushing as a strategy to prevent bacterial colonization of vascular access devices. Medical Devices: Evidence and Research. 2014:379.
[32] Bishop L, Dougherty L, Bodenham A, Mansi J, Crowe P, Kibbler C, et al. Guidelines on the insertion and management of central venous access devices in adults. International Journal of Laboratory Hematology. 2007;29(4):261–78.
[33] Guiffant G, Durussel JJ, Merckx J, Flaud P, Vigier JP, Mousset P. Flushing of Intravascular Access Devices (IVADs) - Efficacy of Pulsed and Continuous Infusions. The Journal of Vascular Access. 2011;13(1):75–8.
[34] Ngo A, Murphy S. A Theory-based Intervention to Improve Nursesʼ Knowledge, Self-efficacy, and Skills to Reduce PICC Occlusion. Journal of Infusion Nursing. 2005;28(3):173–81.
[35] Royon L, Durussel J, Merckx J, Flaud P, Vigier J, Guiffant G. The fouling and cleaning of venous catheters: A possible optimization of the process using intermittent flushing. Chemical Engineering Research and Design. 2012;90(6):803–7.
[36] Vigier J, Merckx J, Coquin J, Flaud P, Guiffant G. The use of a hydrodynamic bench for experimental simulation of flushing venous catheters: impact on the technique. Itbm-Rbm. 2005;26(2):147–9.
[37] Gorski LA. The 2016 Infusion Therapy Standards of Practice. Home Healthcare Now. 2017;35(1):10–8.
[38] Chan A-W, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. Bmj. 2013;346(jan08 15).
[39] ECDC, European Centre for Disease Prevention and Control. Inquérito de prevalência de infeções associadas aos cuidados de saúde e utilização de antimicrobianos nos hospitais de agudos na Europa. Stockholm: ECDC; 2012.
[40] WHO, World Health Organization. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Geneve: WHO; 2008.
[41] Boutron I, Guittet L, Estellat C, Moher D, Hróbjartsson A, Ravaud P. Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments. PLoS Medicine. 2007;4(2).
[41] WHO, World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894. Geneve: WHO; 2000.
[42] Steffens A, Brandão D. Introdução à Terapia intravenosa: visão global. In: Malagutti W, Roehrs H, editors. Terapia intravenosa: atualidades. São Paulo: Martinari; 2012, p.33-44.
[43] Keogh S, Flynn J, Marsh N, Mihala G, Davies K, Rickard C. Varied flushing frequency and volume to prevent peripheral intravenous catheter failure: a pilot, factorial randomised controlled trial in adult medical-surgical hospital patients. Trials. 2016;17(1).
[44] Marsh N, Webster J, Flynn J, Mihala G, Hewer B, Fraser J, et al. Securement Methods for Peripheral Venous Catheters to Prevent Failure: A Randomised Controlled Pilot Trial. The Journal of Vascular Access. 2015;16(3):237–44.
[45] Rickard CM, Webster J, Wallis MC, Marsh N, Mcgrail MR, French V, et al. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. The Lancet. 2012;380(9847):1066–74.
[46] Tuffaha HW, Rickard CM, Webster J, Marsh N, Gordon L, Wallis M, et al. Cost-Effectiveness Analysis of Clinically Indicated Versus Routine Replacement of Peripheral Intravenous Catheters. Applied Health Economics and Health Policy. 2014;12(1):51–8.
[47] Ullman AJ, Cooke ML, Gillies D, Marsh N, Daud A, Mcgrail MR, et al. Optimal timing for intravascular administration set replacement. Cochrane Database of Systematic Reviews. 2013.
[48] Braga LM, Salgueiro-Oliveira AS, Henriques MAP, Rodrigues MA, Rodrigues CJV, Pereira SAG, Parreira PMSD. Tradução e adaptação da Phlebitis Scale para a população portuguesa. Revista de Enfermagem Referência. 2016; Série IV(11): 101-109.
[49] Braga LM, Salgueiro-Oliveira AS, Henriques MAP, Arreguy-Sena C, Parreira PMSD. Adaptação transcultural da Infiltration Scale para o português. Acta Paulista de Enfermagem. 2016b; 29(1): 93-99.
[50] Gupta S. Intention-to-treat concept: A review. Perspectives in Clinical Research. 2011;2(3):109.
[51] Panel on Handling Missing Data in Clinical Trials, National Research Council. The prevention and treatment of missing data in clinical trials. Washington DC, National Academies Press, 2010.
[52] Sydes MR, Altman DG, Babiker AB, Parmar MK, Spiegelhalter DJ, DAMOCLES Group. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Clin Trials 2004; 1:48-59.
[53] CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. Bmj. 2011;343(sep29 2):d6131–d6131.
[54] Flanagin A, Fontanarosa PB, DeAngelis CD. Autorship for research groups. JAMA 2002; 288:3166-8.
[55] Matheson A. How industry uses the ICMJE guidelines to manipulate authorship and how they should be revised. PLoS Med 2011; 8:e1001072.
[56] European Commission. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices. Brussels, Belgium: Author; 2017.
[57] International Organization for Standardization. ISO 14155: Clinical investigation of medical devices for human subjects – Good clinical practices. Geneva, Switzerland: Author; 2011.
[58] International Organization for Standardization ISO 14971: Medical devices – application of risk management to medical devices. Geneva, Switzerland: Author; 2012.
[59] Dillon M, Curran J, Martos R, Walsh C, Walsh J, Al-Azawi D, et al. Factors that affect longevity of intravenous cannulas: a prospective study. Qjm. 2008;101(9):731–5.
[60] Dunda S, Demir E, Mefful O, Grieb G, Bozkurt A, Pallua N. Management, clinical outcomes, and complications of acute cannula-related peripheral vein phlebitis of the upper extremity: A retrospective study. Phlebology: The Journal of Venous Disease. 2014;30(6):381–8.